Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention.

Authors :: O'Shea, J. Conor
Hafley, Gail E.
Greenberg, Sally
Hasselblad, Vic
Lorenz, Todd J.
Kitt, Michael M.
Strony, John
Tcheng, James E.
Source :: JAMA: Journal of the American Medical Association; 5/16/2001, Vol. 285 Issue 19, p2468, 6p, 1 Diagram, 3 Charts, 3 Graphs
Publication Year :: 2001
Abstract: Presents a study to determine whether the beneficial effects of eptifibatide persist at six months after treatment, in light of trials which showed the efficacy of adjunctive, double-bolus eptifibatide therapy in reducing ischemic complications of nonurgent coronary stent implantation. Design; Setting; Participants; Intervention; Main outcome measures; Results; Conclusion.

Subjects :: CORONARY heart disease treatment
HEART diseases
ISCHEMIA
THERAPEUTICS

Full Text Access

Tools